loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X

Technical details about Blarcamesine, learn more about the structure, uses, toxicity, action, side effects and more

Client Email Product
Menu
2D Structure
1. Also known as: 195615-83-9, Avex-73, Thd-dp-fm, Ae-37, Ae37, Blarcamesine [usan]
Molecular Formula
C19H23NO
Molecular Weight
281.4  g/mol
InChI Key
BOTHKNZTGGXFEQ-UHFFFAOYSA-N
FDA UNII
9T210MMZ3F

1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-(2,2-diphenyloxolan-3-yl)-N,N-dimethylmethanamine
2.1.2 InChI
InChI=1S/C19H23NO/c1-20(2)15-18-13-14-21-19(18,16-9-5-3-6-10-16)17-11-7-4-8-12-17/h3-12,18H,13-15H2,1-2H3
2.1.3 InChI Key
BOTHKNZTGGXFEQ-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CN(C)CC1CCOC1(C2=CC=CC=C2)C3=CC=CC=C3
2.2 Other Identifiers
2.2.1 UNII
9T210MMZ3F
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Anavex2-73

2. Tetrahydro-n, N-dimethyl-2,2-diphenyl-3-furanmethanamine Hydrochloride

2.3.2 Depositor-Supplied Synonyms

1. 195615-83-9

2. Avex-73

3. Thd-dp-fm

4. Ae-37

5. Ae37

6. Blarcamesine [usan]

7. Anavex-2-73

8. 9t210mmz3f

9. Tetrahydro-n,n-dimethyl-2,2-diphenyl-3-furanemethanamine

10. 1-(2,2-diphenyloxolan-3-yl)-n,n-dimethylmethanamine

11. Blarcamesine (usan)

12. Tetrahydro-n,n-dimethyl-2,2-diphenyl-3-furanmethanamine

13. 3-furanmethanamine, Tetrahydro-n,n-dimethyl-2,2-diphenyl-

14. 1-(2,2-diphenyltetrahydrofuran-3-yl)-n,n-dimethylmethanamine

15. (r)-1-(2,2-diphenyltetrahydrofuran-3-yl)-n,n-dimethylmethanamine

16. Unii-9t210mmz3f

17. Anavex

18. Ae 37

19. Blarcamesine [inn]

20. An2/avex-73

21. Avex-73?

22. Schembl181634

23. Chembl4297224

24. Gtpl11586

25. Dtxsid60941344

26. Bcp23552

27. Ex-a3143

28. Bdbm50559171

29. Anavex-2-73 Free Base (blarcamesine)

30. Db05592

31. Sb17187

32. Ncgc00387227-01

33. Ac-35490

34. Hy-105296

35. Cs-0025655

36. D11383

37. D87137

38. Q25110485

39. Rac-1-((3r)-2,2-diphenyloxolan-3-yl)-n,n-dimethylmethanamine

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 281.4 g/mol
Molecular Formula C19H23NO
XLogP33.5
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count2
Rotatable Bond Count4
Exact Mass281.177964357 g/mol
Monoisotopic Mass281.177964357 g/mol
Topological Polar Surface Area12.5 Ų
Heavy Atom Count21
Formal Charge0
Complexity298
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Investigated for use/treatment in breast cancer.


Post Enquiry
POST ENQUIRY